Can Progesterone Increase Blood Pressure?

Natural progesterone, on its own, does not typically raise blood pressure. In fact, most of the experimental evidence points in the opposite direction: progesterone relaxes blood vessels, promotes sodium excretion, and boosts the production of nitric oxide, a molecule that keeps arteries flexible. The confusion arises because “progesterone” is routinely conflated with synthetic progestins found in many birth control pills and hormone therapies, and those synthetic versions can behave very differently in the cardiovascular system. Untangling this distinction matters, because the practical answer for someone taking hormones depends heavily on which compound they are actually using.

How Natural Progesterone Relaxes Blood Vessels

At the level of the blood vessel wall, progesterone acts as a vasodilator. Animal experiments have shown that intravenous progesterone significantly blunts the blood-pressure-raising response to norepinephrine, one of the body’s main vasoconstricting chemicals. When researchers tested progesterone directly on isolated artery strips that had been forced to contract, the hormone produced dose-dependent relaxation. The mechanism traced back to calcium signaling: progesterone inhibited the inflow of calcium through L-type calcium channels in smooth muscle cells, reducing the calcium surge that muscles need in order to squeeze a vessel shut. In those experiments, calcium entry dropped by roughly a third compared to controls.

Progesterone also stimulates the production of nitric oxide in the cells lining blood vessels. Multiple studies on human endothelial cells have found that progesterone activates the enzyme responsible for generating nitric oxide, boosting both its expression and its activity.

² When the progesterone receptor was blocked in rats using an antagonist drug, nitric oxide synthase expression fell and vascular relaxation was impaired, reinforcing the idea that progesterone actively helps keep vessels dilated.

One study added a wrinkle. When researchers gave a single dose of natural progesterone to healthy postmenopausal women and measured forearm blood flow, they found that progesterone actually decreased flow and increased local vascular resistance. Mean arterial pressure and heart rate did not change, but circulating norepinephrine rose modestly. The authors concluded that progesterone’s acute vascular effect in this context was the opposite of estrogen’s, tightening rather than relaxing peripheral vessels.

⁴ This result does not necessarily contradict the vasodilatory findings from lab work; it suggests that in living humans, the picture is messier than in isolated arteries, and progesterone’s effects on the sympathetic nervous system can compete with its direct relaxing action on vessel walls.

The Sodium Connection

Progesterone is a natural antagonist of aldosterone, the hormone that tells your kidneys to hold onto sodium and water. When progesterone occupies the same receptor that aldosterone uses, it blocks aldosterone’s salt-retaining signal, causing the body to excrete more sodium. In animal experiments, doses of progesterone completely blocked the sodium-retaining effect of aldosterone, and the mechanism was traced to direct competition at the kidney’s mineralocorticoid receptor.

⁵

This is why progesterone levels in the second half of the menstrual cycle trigger a compensatory rise in the renin-angiotensin-aldosterone system. The body senses sodium leaving and ramps up aldosterone production to compensate, which largely prevents blood pressure from falling.

⁶ The net effect is roughly a wash: progesterone pushes sodium out, aldosterone pushes harder to keep it in, and blood pressure stays about the same. In practice, the antimineralocorticoid property of progesterone works against blood pressure elevation rather than causing it.

That said, the antimineralocorticoid punch of progesterone is weaker in living humans than test-tube experiments might predict. When progesterone was infused at high levels in a human study, the increase in sodium excretion was modest despite concentrations far exceeding aldosterone.

⁷ Enzymes in the kidney partly inactivate progesterone before it reaches the receptor, dampening the effect. So while the direction is blood-pressure-friendly, the magnitude is limited.

What Happens to Blood Pressure During the Menstrual Cycle

The luteal phase of the menstrual cycle is the body’s natural experiment in high progesterone. Levels rise roughly 25-fold compared to the first half of the cycle. If progesterone raised blood pressure, you would expect to see a clear jump during those two weeks. Studies looking at this have generally not found one. A study measuring central and peripheral blood pressures across the cycle found no change between the follicular and luteal phases, despite markedly higher progesterone and estradiol in the luteal phase.

⁸

There is, however, an interesting nuance. A separate study found that while resting blood pressure stayed the same across the cycle, the blood pressure response to a carbon dioxide challenge was significantly amplified during the luteal phase. Systolic pressure rose about twice as steeply per unit of CO₂ when progesterone was high compared to when it was low.

⁹ This suggests that progesterone may not raise resting pressure, but it could make the cardiovascular system more reactive to certain stressors. The mechanism is not fully clear, though progesterone’s stimulatory effect on the sympathetic nervous system and on ventilatory drive are likely contributors.

Why Synthetic Progestins Are a Different Story

This is where the confusion gets dangerous. The word “progestin” is an umbrella term covering dozens of synthetic molecules designed to mimic progesterone’s effects on the uterine lining. They do that job well enough for contraception and hormone therapy. But their side effects on blood vessels, the kidneys, and the sympathetic nervous system vary enormously depending on their chemical backbone.

Many older synthetic progestins have partial androgenic or glucocorticoid activity, which means they can oppose the beneficial cardiovascular effects of estrogen and nudge blood pressure upward.

¹⁰ In animal models of hypertension, synthetic progestins that lacked antimineralocorticoid activity did not lower blood pressure; instead, they tended to raise it slightly. Only drospirenone, a synthetic progestin specifically designed to retain antimineralocorticoid activity (it is structurally related to the blood pressure drug spironolactone), produced a small but significant decrease in blood pressure and body fluid volume.

¹¹

The practical implication: when someone reports that “progesterone raised my blood pressure,” the culprit is very often a synthetic progestin with androgenic leanings, not bioidentical progesterone. The distinction is real, pharmacologically meaningful, and routinely ignored in casual conversation and even in some clinical settings.

Birth Control Pills and Blood Pressure

Combined oral contraceptives (the standard pill containing both an estrogen and a progestin) have a well-documented association with small but meaningful increases in blood pressure. The link was first noticed when early pills contained much higher estrogen doses, but epidemiologic evidence has continued to show a smaller, still significant association even with modern low-dose formulations.

¹² The estrogen component is thought to be the primary driver, mainly through its effect on liver production of angiotensinogen, a precursor in the blood-pressure-regulating renin-angiotensin system. But the progestin component matters too: pills containing androgenic progestins may compound the problem, while drospirenone-containing pills may partially offset it.

Progestin-only contraceptives tell a different story. A literature review found that progestin-only pills showed no significant association with high blood pressure over follow-up periods of two to three years.

¹³ A systematic review and meta-analysis of progestin-only contraceptives broadly confirmed that finding, reporting no overall effect on blood pressure.

¹⁴

Injectable depot medroxyprogesterone acetate (DMPA), however, may be a special case. One cross-sectional study of women using three-month DMPA injections found a significant association between longer duration of use and the incidence of hypertension.

¹⁵ That study was small and observational, so it cannot prove causation, but it aligns with the idea that medroxyprogesterone acetate, a progestin with some glucocorticoid activity, may behave differently from natural progesterone or from progestin-only pills that use other compounds. Clinical guidelines have generally recommended progestin-only contraceptives or drospirenone-containing combined pills for women who already have hypertension.

¹⁶

Progesterone During Menopause Therapy

Postmenopausal women on combined hormone replacement therapy (estrogen plus a progestin) sometimes worry about what the progestin component does to their blood pressure. A three-month randomized, placebo-controlled trial in healthy early postmenopausal women found no differences in systolic or diastolic blood pressure between women receiving progesterone therapy and those on placebo.

¹⁷

That said, progesterone can blunt some of estrogen’s vascular benefits. In young women whose own hormone production was temporarily suppressed and then replaced, transdermal estradiol significantly improved flow-mediated dilation, a measure of how well arteries expand in response to increased blood flow. When oral progesterone was added, that improvement disappeared entirely.

¹⁸ This does not mean progesterone raised blood pressure, but it suggests that in menopausal therapy, adding progesterone may attenuate some of the vascular protection estrogen provides. The clinical relevance of this finding over longer time frames is still debated.

Progesterone, Pregnancy, and Preeclampsia

Pregnancy is a state of massively elevated progesterone, and understanding progesterone’s role in pregnancy-related blood pressure disorders like preeclampsia has been an active area of research. The relationship runs opposite to what you might expect if progesterone were a blood-pressure-raising hormone: women with preeclampsia tend to have lower progesterone levels, not higher ones. One study found that serum levels of both estrogen and progesterone were significantly reduced in women with preeclampsia compared to healthy pregnant controls.

¹⁹

A separate study measuring third-trimester hormone levels confirmed that the two groups had similar progesterone concentrations, but the preeclampsia group had lower estrogen and higher testosterone.

²⁰ So while the data do not uniformly agree on whether progesterone is significantly lower in preeclampsia, no study has found it to be significantly higher. The pattern suggests that adequate progesterone may be part of the normal cardiovascular adaptation to pregnancy rather than a contributor to hypertensive disorders.

Part of this protective effect may be mediated by the brain. Progesterone is converted in the body to allopregnanolone, a neurosteroid that enhances inhibitory signaling in brain regions involved in blood pressure regulation. During normal pregnancy, increased allopregnanolone in the brainstem helps suppress sympathetic outflow, keeping blood pressure in check despite the dramatic increases in blood volume and cardiac output that pregnancy demands.

²¹

Allopregnanolone and Brain-Mediated Blood Pressure Control

The neurosteroid angle extends beyond pregnancy. Researchers have identified an antihypertensive action of allopregnanolone in a mouse model of neurogenic hypertension, the kind driven by excessive sympathetic nervous system activity rather than by kidney or vascular problems. Allopregnanolone enhances a type of inhibitory receptor in brain areas like the amygdala and hypothalamus that regulate stress responses and cardiovascular tone.

²² This is still early-stage research in animals, but it opens an intriguing possibility: progesterone’s metabolites may have therapeutic potential for certain forms of hypertension, rather than being a cause of it.

Genetic Variation in Progesterone Receptor Sensitivity

Not everyone responds to progesterone the same way, and genetics plays a role. One study examined a common variant in the progesterone receptor gene known as PROGINS and its effect on blood pressure during pregnancy. The variant alone had no measurable impact. But when the researchers stratified by the sex of the fetus, a striking pattern emerged: mothers who carried two copies of the variant and were pregnant with a boy had significantly lower systolic blood pressure in the first trimester (about 108 mmHg) compared to mothers with the same genotype carrying a girl (about 117 mmHg). Diastolic pressure showed a similar split.

²³

This finding is a reminder that the progesterone-blood pressure relationship is not one-size-fits-all. Receptor genetics, fetal hormonal contributions, and probably other factors that have not yet been studied all modulate what progesterone actually does in any individual person’s cardiovascular system. It is also a reminder that single-gene studies in pregnancy are notoriously hard to replicate, so this particular observation should be taken as hypothesis-generating rather than settled science.

Practical Considerations If You Take Hormones

For anyone wondering whether their progesterone prescription is raising their blood pressure, a few distinctions are worth keeping straight:

Bioidentical progesterone: Oral micronized progesterone (sold as Prometrium in the U.S.) is chemically identical to the hormone your body produces. Clinical trial data show it does not raise blood pressure over several months of use, and its antimineralocorticoid activity mildly favors sodium excretion.
Drospirenone: This synthetic progestin was designed to mimic progesterone’s aldosterone-blocking properties. It can modestly lower blood pressure and is the progestin most often recommended for women with existing hypertension.
Older synthetic progestins: Medroxyprogesterone acetate, norethindrone, levonorgestrel, and similar compounds lack antimineralocorticoid activity and have varying degrees of androgenic or glucocorticoid action. These are more likely to have neutral or slightly unfavorable effects on blood pressure, especially in combination with ethinyl estradiol in a combined pill.
Injectable DMPA: Depot medroxyprogesterone acetate uses high doses of a single progestin delivered every three months. Some observational data suggest an association with hypertension over prolonged use, but the evidence is not definitive.

If you have been told to avoid estrogen-containing contraceptives because of blood pressure concerns, a progestin-only option (pill, implant, or hormonal IUD) is generally considered safe from a blood pressure standpoint. Monitoring is still a good idea in the first few months, particularly with injectable DMPA, but the bulk of the evidence supports this approach.